Tags

Type your tag names separated by a space and hit enter

Osteoporosis - pharmacological prevention and management in older people.
Aust Fam Physician. 2012 Mar; 41(3):110-8.AF

Abstract

BACKGROUND

Osteoporosis remains undertreated in Australian primary care, with as few as 30% of postmenopausal women with a fracture and 10% of men with osteoporosis receiving pharmacological treatment.

OBJECTIVE

This article presents an overview of the pharmacological management of osteoporosis in older people in the general practice setting.

DISCUSSION

Lifestyle factors and ensuring adequate calcium and vitamin D intake are important in preventing and treating osteoporosis. Pharmacological treatments are recommended for patients with a minimal trauma fracture, for those aged 70 years or over with a T-score of -3.0 or lower, or for those who are currently taking prolonged high dose corticosteroids and who have a T-score of -1.5 or lower. Bisphosphonates are recommended as first line therapy for established postmenopausal osteoporosis. Medicine selection is guided by patient gender, menopausal status, medical and fracture history, patient preference and eligibility for government subsidy.

Links

FREE Publisher Full Text

Authors+Show Affiliations

Bell JS
Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia. bell@unisa.edu.au
Blacker N
No affiliation info available
Edwards S
No affiliation info available
Frank O
No affiliation info available
Alderman CP
No affiliation info available
Karan L
No affiliation info available
Husband A
No affiliation info available
Rowett D
No affiliation info available

MeSH

AgedAged, 80 and overBone DensityBone Density Conservation AgentsCalciumDiphosphonatesFemaleFractures, BoneHumansMaleOsteoporosisRisk FactorsVitamin D

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22396923

Citation

Bell, J Simon, et al. "Osteoporosis - Pharmacological Prevention and Management in Older People." Australian Family Physician, vol. 41, no. 3, 2012, pp. 110-8.
Bell JS, Blacker N, Edwards S, et al. Osteoporosis - pharmacological prevention and management in older people. Aust Fam Physician. 2012;41(3):110-8.
Bell, J. S., Blacker, N., Edwards, S., Frank, O., Alderman, C. P., Karan, L., Husband, A., & Rowett, D. (2012). Osteoporosis - pharmacological prevention and management in older people. Australian Family Physician, 41(3), 110-8.
Bell JS, et al. Osteoporosis - Pharmacological Prevention and Management in Older People. Aust Fam Physician. 2012;41(3):110-8. PubMed PMID: 22396923.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Osteoporosis - pharmacological prevention and management in older people. AU - Bell,J Simon, AU - Blacker,Natalie, AU - Edwards,Sue, AU - Frank,Oliver, AU - Alderman,Christopher P, AU - Karan,Lesh, AU - Husband,Alan, AU - Rowett,Debra, PY - 2012/3/8/entrez PY - 2012/3/8/pubmed PY - 2012/9/15/medline SP - 110 EP - 8 JF - Australian family physician JO - Aust Fam Physician VL - 41 IS - 3 N2 - BACKGROUND: Osteoporosis remains undertreated in Australian primary care, with as few as 30% of postmenopausal women with a fracture and 10% of men with osteoporosis receiving pharmacological treatment. OBJECTIVE: This article presents an overview of the pharmacological management of osteoporosis in older people in the general practice setting. DISCUSSION: Lifestyle factors and ensuring adequate calcium and vitamin D intake are important in preventing and treating osteoporosis. Pharmacological treatments are recommended for patients with a minimal trauma fracture, for those aged 70 years or over with a T-score of -3.0 or lower, or for those who are currently taking prolonged high dose corticosteroids and who have a T-score of -1.5 or lower. Bisphosphonates are recommended as first line therapy for established postmenopausal osteoporosis. Medicine selection is guided by patient gender, menopausal status, medical and fracture history, patient preference and eligibility for government subsidy. SN - 0300-8495 UR - https://www.unboundmedicine.com/medline/citation/22396923/Osteoporosis___pharmacological_prevention_and_management_in_older_people_ L2 - http://www.racgp.org.au/afp/201203/45953 DB - PRIME DP - Unbound Medicine ER -